Professor of Healthcare Management and Director of the Center for Healthcare Management, Germany, and Columbia University, New York, USA
Katharina Janus, a professor of healthcare management in Germany and at Columbia University New York, is the founder and managing director of the Center for Healthcare Management and the president and CEO of the consulting network ENJOY STRATEGY. She has twenty years of global healthcare management experience in science and corporate practice. Starting her career in managed care at one of the largest hospital chains in the United States, she has learned about challenges on the shop floor before turning to academia where she continued to pursue applied research. She then left her tenured position in Germany to lead the Center for Healthcare Management and reinvent research and education that is in constant dialogue with practice. Her global consulting network ENJOY STRATEGY supports many of the Center’s projects on the implementation side.
She has been invited frequently as a speaker and moderator to contribute her global domain expertise and in-depth knowledge of healthcare markets and trends. In this respect, she has helped major multinational companies with market access strategy and business development to facilitate on-site implementation in various cultural environments.
Dr. Janus was a 2006-07 Harkness Fellow in Health Care Policy at The Commonwealth Fund, a Rockefeller Foundation academic fellow in 2012 and a Brocher Foundation resident in 2014. She was also one of the youngest tenured professors and female board members of a DAX company appointed in Germany. Dr. Janus earned her Master’s Degree in Business Administration at the Universities of Hamburg and the Université Panthéon-Sorbonne Paris in 2000. She holds a PhD in Business and Social Sciences from Helmut-Schmidt-University in Hamburg (2003) and the German qualification as a full professor (2009).
She has been a ballet dancer before she started her career in healthcare management which inspired her to create sculptures whenever her busy schedule permits. Her creative approaches to strategy consulting frequently are influenced by her artistic upbringing and education.
General Director, Ile-de-France Region, Paris, France.
Deputy CEO of the French Hospital Federation, institution that, for over 100 years, gathers and represents all public hospitals in France, Cédric ARCOS is hospital director graduated from Sciences Po, French National School of Public Health and High Institute of Social Protection. He occupied different high responsibilities in French hospitals, as Human Resources Director of Universitarian hospital of Lyon and as Chief of staff of this hospital. In the French Hospital Federation, Cédric is in charge of the animation of the hospital network and of the implementation of the reform of governance, drawn by the last law of healthcare, in 2016. He is also in charge of the relations with political leaders and of strategic affairs of the federation.
Since 2012, Cédric Arcos runs a Think Tank, who try to propose systemic reforms for the French healthcare. He is also involved in the European Hospital Federation (HOPE), as the French representative.
At last, Cédric Arcos is in charge of teaching healthcare policies at Sciences Po Paris and is the author of « ethics and management », published in Paris in 2010 and of « Reforms of hospitals and Hospital reform » published in 2014.
Member of the Board of Allianz Private Health Insurance, Germany Former Federal Minister of Health in Germany
Daniel Bahr is a Member of the Board of Allianz Private Health Insurance. He is responsible for sales, distribution and claims management. He is joining the Allianz since November 2014.
In 2014 Daniel Bahr was a Senior Fellow at the Center for American Progress in Washington D.C. and a Visiting Lecturer at the School of Public Health, University of Michigan in Ann Arbor.
He was the federal minister of health in Germany from May 2011 to December 2013. Previously, he joined the German government in 2009 as a parliamentary state secretary to the federal minister of health.
While his time in the ministry he enforced many reforms for the healthcare sector. His priorities as minister were reforming the market for pharmaceutical products and ensuring the sustainability of financing the health care system. He accomplished cancer registries, a new system for organ donation in Germany and a long-term care insurance, so care for people with mental illness is now covered.
He was first elected into the German parliament, the Bundestag, in 2002. From 2002 to 2005, he served as spokesman for demographic development, long-term care, and policies for disabled persons of the Free Democratic Party’s, or FDP’s, parliamentary group in the Bundestag. From 2005 to 2009, he was the health policy spokesman of the FDP parliamentary group. Concurrently, he held the office of FDP state chairman in North Rhine-Westphalia from 2010 to 2012. He acted as the federal chairman of the Young Liberals from 1994 to 2004, and was a member of the FDP Federal Executive Committee.
Daniel Bahr holds a bachelor of science degree in economics and an MBA in business management administration with a focus on international health care and hospital management from Westfaelische-Wilhelms University in Muenster. Before his political career, he worked for the Dresdner Bank AG (now, Commerzbank AG) in Schwerin and Hamburg.
Partner, Head of German Life Sciences Practice, Dentons
Peter Homberg is Partner in the Dentons Frankfurt office. He specializes in IP, corporate law and M&A transactions in the Life Sciences and High-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Peter advises inter alia companies in the pharmaceutical, diagnostics, biotechnology and medical device industry – from startups to large publicly listed companies. Furthermore, he has broad transactional experience in Southeast Asia. Peter is member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. He regularly holds lectures at seminars and conferences, and is also author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.
Mark Lloyd Davies
Senior Director, Government Affairs & Policy, Medical Devices EMEA and Johnson & Johnson Western Markets Lead, Brussels, Belgium
Mark is responsible for fostering a strong and constructive relationship between Johnson & Johnson Medical Devices and Consumer Medical Devices and Government institutions throughout Europe Middle East and Africa (EMEA). This includes the European Commission, Parliament and Council and involves extensive partnering with senior business leaders and government officials, policy makers and other key stakeholders.
Mark is a member of the Johnson & Johnson Medical Devices EMEA Leadership Team and Global Government Affairs & Policy Council for Medical Devices. He has worked for the Pharmaceutical, Consumer and Medical Device divisions of Johnson and Johnson since 2009, and has assumed roles of increasing responsibility in functions such as Communications, Corporate Social Responsibility and Government Affairs.
Mark holds a PhD from the University of Amsterdam, The Netherlands and BSc from the University of London, UK.
Head of Longevity R&D center at SCOR
Razvan Ionescu is leading the Longevity R&D center at SCOR. After obtaining a Master’s Degree in Actuarial Science from ISFA (Institut de Science Financière et d’Assurances), a famous French actuarial school, Razvan joined SCOR in 2007. He worked as an actuary in the R&D department devoted to longevity and mortality risks for 7 years. As a R&D actuary, Razvan main task is to increase our risk knowledge scientific partnerships with academics and monitor technological developments. As a risk expert, Razvan took part in the business effort by developing pricing basis, bringing support to pricing teams and validating guidelines and referrals. Since 2014 Razvan, is leading the R&D Longevity risk center.
Country General Manager of InterSystems France and President of Digital Health Commission Medicine, Paris, France
Carlos strives to highlight InterSystems solutions and position the company as a key player of the digital transformation in the health field. By placing InterSystems as an architect of Connected Health & a GHT Solution provider, Carlos Jaime aims to promote a new vision of health, more connected, more efficient and affordable to all.
Carlos Jaime started his career at AGFA Healthcare where he led the sales functions for 10 years, and then served as Sales Director. He then spent 3 years at Toshiba Healthcare, 2 years in Dräger Medical & 4 year at Philips Healthcare France as Sales Director. Prior to joining InterSystems, Carlos was the Head of Healthcare French division of Samsung Electronics.
Carlos is graduated from an MBA at ESSEC Business School.
Walter C. Kopp
President, Medical Management Services, San Anselmo, CA, USA
Walter Kopp is President of Medical Management Services a healthcare executive management and advisory group specializing in the development of clinically integrated communities. This group has assisted with medical group practice management, medical group and hospital integration, physician succession planning, managed care analysis and contracting, and healthcare technology implementation in Health Systems. Services also include strategic positioning and market analysis, medical group development, contract negotiations, service line development and operations reviews.
A partial list of MMS recent clients include; Sutter Health, City of Hope Medical Group, Blue Shield of California, The Permanente Medical Group, Alta Bates Medical Group, Brown and Toland Medical Group, Hill Physicians Medical Group, Anthem/ Blue Cross of California, St Joseph Heritage Medical Foundation, Santa Rosa Memorial Hospital, Marin General Hospital, Lodi Memorial Community Clinics, Torrance Memorial Medical Center, Salinas Valley Healthcare District, Palm Drive Healthcare District, the American College of Surgeons and Cardiovascular Consultants Medical Group.
Previously, Walter was Chief Operating Officer of Menlo Clinic at Stanford University Medical Center. Walter was also Executive Director of BayCare Medical Group and Assistant VP and Director at St. Luke’s Hospital in San Francisco. In addition, he worked for large accounting firms, Alta Bates Hospital, University of Colorado Hospital, UC San Francisco, and the Ross Valley Medical Group.
Walter has served on various boards of Directors, including the National IPA Coalition, Marin Community Clinic, and the Bay Pacific Health Plan. Walter is founder and current advisor to the California eHealth Collaborative. He earned his BA degree from the University of California, Berkeley and his Masters in Health Administration from the University of Colorado.
Professor, Bocconi University, Milan, Italy
Federico Lega, Ph.D., is professor of healthcare and public management at Bocconi University, Milan, Italy.
Federico Lega, Ph.D., currently serves as a Leader of the executive education for the healthcare sector at SDA Bocconi School of Management (SDA), where he manages a faculty of 40 FTEs professors and – on a yearly base – a portfolio of 30 short-medium term executive courses, 4 master programmes, about 50 customized programmes and about 15 research programmes. He is in charge of the management track at the International Master of Healthcare Management, Economics and Policy (MIHMEP) and until 2009 he has been the Director of the Master in Healthcare Management (MIMS – Italian class). He also serves as a Director of the Master of Science in Public Management and International Organizations (CLAPI) at Bocconi University, where he teaches courses in Public Policy and Administration and as a Head of the unit Strategy and Organization at CERGAS Bocconi, an academic research center on healthcare policy and management. He coordinates researches on strategic planning processes, organizational redesign and development and leads change management projects in hospitals and other health organizations.
He has research and teaching connections with several institutions, such as INSEAD, University of Alabama at Birmingham, York University Management School (UK), Leeds University, Warwick University, King’s Fund London, Stellenbosch – South Africa, Catholic University of Cordoba – Argentina, Management Center of Innsbruck.
His research and teaching interests focus on organization and management of hospitals and health institutions and on modernization, change management and innovation processes in the health sector. He published five books and several articles. He is internal auditor of the Italian Health Economics Association (AIES) and member of the European Health Management Association (EHMA) and active in European COST initiatives on improving healthcare systems.
Professor of Management and Director of Management in Organizations, Ecole des Hautes Etudes en Santé Publique (EHESP), Paris, France
Etienne Minvielle is Professor of Management at the French School of Public Health (EHESP), University of Sorbonne Paris Cité. He holds the Chair of Management and is the Director of the Research unit, Management of HealthCare Organizations (MOS).
He received his MD from the Paris V School of medicine where he did his residency in Public Health. He also received a PhD in Management Science from the Polytechnique School, and also be graduated from the French business school, ESSEC. He spent one year at the Leonard Davis Institute, University of Pennsylvania, during his post-doctoral period. He recently became the director of the Master of Science in Health Care Management (EHESP, AP-HP, Ecole du Santé du Val-de-Grace, Paris VII).
His research seeks to understand the effect of new delivery systems (new forms of payment, patient pathways, quality improvement incentives, customized service) on healthcare performance. He has been continuously funded by the French Ministry of Health and the High Authority for Health for developing a national quality program, including quality indicators, ranking methods and paying for quality system, since 2003. He is currently the principal investigator of a cancer navigation research supported by the French Agency for Research which assesses the impact of patient portal on oral drugs’ observance. He is also the coordinator of a study sponsored by the French Agency for Health care Performance for designing a composite score of hospital performance (based on the medico-administrative database named Hospidiag). His research has been published in high-impact peer-reviewed journals (The BMJ, Medical Care, Social Science and Medicine, Public Administration review, International Journal of production economics).
He serves on numerous expert panels advising policy makers and government officials on the use of quality improvement incentives in health care. In addition to his research, Etienne Minvielle is also advisor at Gustave Roussy, a leading European Cancer center, for implementing innovative patient pathways. He works closely with the CEO and the board of directors to help design innovative patient pathways.
Member of the Board of Management of ERGO Germany AG
Christian Molt is a Member of the Board of Management of ERGO Germany AG, ERGO Versicherung AG, ERGO Vorsorge Lebensversicherung AG and DKV Deutsche Krankenversicherung AG, responsible for Customer and Sales Services.
ERGO is one of the major insurance groups in Germany and Europe. Worldwide, the Group is represented in over 30 countries and concentrates on Europe and Asia. In its home market of Germany, ERGO ranks among the leading providers across all segments.
Prior to his current position, Christian Molt was with Allianz for over twenty years. His latest position at Allianz was as Head of Department for Steering, Analysis and Strategy in the Operations Division, thereby focusing on the transformation of the company into a customer-oriented and efficient service organization. Before that, Christian Molt was a Member of the Board of Management of Allianz Private Krankenversicherungs-AG and Vereinte Spezial Krankenversicherung AG, in Munich, responsible for the Specialist Unit for Sales and Operations, Corporate Insurance, Claims and Health Management, Insurance Law and Data Protection.
From 2005 to 2008 he was CEO and Member of the Board of Directors of Allianz China Life Insurance Company Ltd., Shanghai.
Christian Molt studied Mathematical Economics at the University of Ulm and has an MSc in Applied Mathematics from the University of Southern California, Los Angeles.
Head of Health and Longevity R&D at SCOR
Daria Ossipova is Head of Health and Longevity R&D at SCOR and leads five centers of excellence situated around the globe: Longevity (Paris), Health (Cologne), Critical Illness (Singapore), Long Term Care (Paris) and Disability, Unemployment and Special Risks (Paris). She joined SCOR in 2002 and since then has built a strong multi-cultural and cross-functional team of specialists: demographers, mathematicians, epidemiologists and statisticians, who provide their expertise and modelling capacities to the insurance industry to optimize profitability, expand insurance coverage and provide new solutions adapted to protection and prevention needs.
Daria’s teams conduct research projects, assist local entities with product development, establish scientific partnerships with academics and contribute to the risk management policy as well as capital modelling. She holds a Master’s degree in Mathematics with honors from St Petersburg State University and a PhD (with distinction) in Mathematics from Hull University in UK and subsequently completed a post-doctorate fellowship at the French National Scientific Research Centre (CNRS). Daria then chose to go into applied research, gradually taking the lead role at SCOR in the successful combination of research and its practical applications.
CEO AMEOS Hospital Group, Zurich
Axel Paeger, M.D., has served as CEO of AMEOS Hospital Group since 2003. Prior to his current position, Dr. Paeger was chief managing officer of Asklepios Kliniken GmbH. Before that, he was a member of the Pacific Health Corporation, Inc. board. He has also served as an associate partner for Health Care Consultancy in Cleveland, OH, USA.
AMEOS is among Europe’s leading healthcare service providers and primarily serves German speaking regions (with today 68 facilities in the fields of hospitals, long-term mental care facilities and long-term elderly care facilities).
David P. Roye Jr.
Professor and Executive Medical Director, New-York-Presbyterian Morgan Stanley Children’s Hospital Columbia, Cerebral Palsy Center, NY, USA
Dr. David Roye Jr., the St. Giles Professor of Pediatric Orthopaedic Surgery, Director of Pediatric Orthopaedic Surgery at the NewYork-Presbyterian Morgan Stanley Children’s Hospital, and Executive Medical Director of the Columbia Cerebral Palsy Center, has been a member of the Columbia faculty since 1980. He has dedicated his career to providing and improving the medical care of children with orthopaedic problems around the world, teaching future surgeons, and conducting high quality clinical research in the field of pediatric orthopaedics. Dr. Roye’s main research focus is on multicenter pediatric spinal deformity studies and multidisciplinary Cerebral Palsy research. He is a world recognized leader in clinical outcome studies in the field of pediatric orthopaedics and awarded numerous grants to conduct cutting edge outcome studies. He has written over 100 peer-reviewed articles, reviews, and book chapters, and has lectured at forums world-wide. Additionally, he has participated in the delivery of medical care overseas since 1987 to improve healthcare in developing countries. Aware of the challenges facing healthcare reform in China, Dr. Roye founded the International Healthcare Leadership (IHL) program. The IHL seeks to address the lack of healthcare policy and management training in China in order to contribute to sustainable solutions to solve a range of skill-related challenges in the Chinese healthcare system. The organization’s objective is to establish an executive-level certificate program at Mailman School of Public Health at Columbia University. IHL has hosted various symposiums and seminars in China and the U.S. and has consulted with Chinese healthcare organizations. Dr. Roye has won many awards including in 2009, the American Association of Orthopaedic Surgeons Humanitarian of the Year Award, in 2010 the Columbia University Arnold Gold Humanism Award and in 2012 the Columbia University Alumni Medal for Distinguished Service.
National Vice President Business Development and Innovation, Kaiser Permanente, Oakland, USA
Chris Stenzel is Vice President for Business Development and Innovation for national health plan functions at Kaiser Permanente. His role is to improve Kaiser Permanente’s competitive position, growth and performance through innovative new business initiatives and relationships. He currently oversees a portfolio of initiatives ranging from telehealth enabled retail care to clinical centers of excellence to technology innovation partnerships with large employers.
Kaiser Permanente is the nation’s largest not-for-profit healthcare organization with over 12 million members, 220,000 employees and 22,000 physicians. Kaiser Permanente generated approximately $73 billion in revenue in 2017 and operates 38 hospitals and over 600 medical offices.
As part of his business development role, Chris currently serves as a member of Kaiser Permanente’s corporate venture capital oversight committee and is a board member for one of Kaiser Permanente’s portfolio companies. He serves on the Board of the Health Transformation Alliance, a coalition of 46 large employers seeking to transform healthcare to a system of healthier outcomes and better value. Chris co-leads Kaiser Permanente’s Employer Innovation Council and serves on the National Business Group on Health – Health Innovations Industry Council.
During his 25 years with Kaiser Permanente, Chris has held a wide range of leadership positions within the medical groups, health plan and hospital areas, including strategic planning, information technology management, and business development. He was the CEO of start-up company owned by Kaiser Permanente that grew to $20 million in revenue. Chris led the creation of Kaiser Permanente’s highly successful corporate venture capital program, which now has $400 million in committed and invested capital in over 60 innovative healthcare companies. In that capacity, he served on the boards of seven start-up companies and was an active observer on six others. Prior to joining Kaiser Permanente, Chris was a senior manager with Accenture (then Andersen Consulting). In this role, he led strategic management and information technology consulting projects for large companies in the United States and internationally.
Chris has a bachelor’s degree in Economics from University of California Los Angeles and an MBA in Finance with distinction from the University of San Francisco.